Search results
FDA Advisers Like Lilly’s Alzheimer’s Drug. It’s Good News for Biogen.
Barrons.com· 7 days agoSTOCK ALERT A new Eli Lilly treatment for Alzheimer’s disease appears set to nab Food and Drug...
Supreme Court rules in abortion medication case, finds group lacked standing to challenge FDA ...
Fox News· 5 days agoThe Supreme Court on Thursday ruled against a challenge to the Food and Drug Administration's (FDA)...
A new drug could slow Alzheimer's. But can patients get it?
Today's News-Herald· 1 day agoAs I explained last year, when Biogen and Eisai’s Leqembi became the first anti-amyloid drug to...
Two Is Better Than One in the Alzheimer’s Market
The Wall Street Journal· 20 hours agoThe approval of Eli Lilly’s Alzheimer’s drug donanemab could help build momentum for Biogen’s struggling drug Leqembi.
Gateway - Quartz
Quartz· 3 hours agoModerna stock rose after new data suggested that its experimental vaccine could be used to treat a variety of cancers. The American Society of Health-System Pharmacists said the number of ongoing ...
Unanimous Supreme Court preserves access to widely used abortion medication
McComb Enterprise-Journal· 10 hours agoWade two years ago. The nine justices ruled that abortion opponents lacked the legal right to sue over the federal Food and Drug Administration’s approval
Psychedelic therapy push renewed on Hill
Axios· 9 hours agoLawmakers are redoubling efforts to secure psychedelic treatments for veterans after an FDA advisory committee overwhelmingly recommended against what would be the first such drug< ...
Merck Gets FDA Approval for Keytruda to Treat Endometerial Cancer
Market Watch· 9 hours agoPublished: June 17, 2024 at 5:41 p.m. ETShareResizeBy Adam L. CataldoMerck said its blockbuster cancer drug Keytruda has been approved for the treatment of adult patients ...
FDA panel endorses approval of Alzheimer’s drug shown to slow progression of disease
WSB Radio· 7 days agoA panel of independent advisors to the U.S. Food and Drug Administration has recommended an...
Lilly’s Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP.
The Wall Street Journal· 4 days agoIt takes a long time.” A potential avenue for relief is to make a GLP-1 drug in pill form. Lilly has...
